Chemical Engineering Department, Texas Tech University, Lubbock, Texas, TX, USA.
School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Trends Biotechnol. 2018 Jul;36(7):686-699. doi: 10.1016/j.tibtech.2018.02.008. Epub 2018 Mar 24.
The prevalence of autoimmune disorders is increasing steadily and there is no permanent cure available. Immunomodulation through repeated exposure of antigens, known as antigen-specific immune tolerance or antigen-specific immunotherapy (ASI), is a promising approach to treat or prevent autoimmune disorders. Different optimization protocols (immunization routes, delivery systems, and approaches) are being developed to implement ASI against self-proteins. Including appropriate adjuvants, altered peptide ligand, and using multipeptides are approaches that can be used to specifically target autoimmunity. This review explores various ASI application methods, including different routes of antigen-specific sensitization, delivery systems, immunomodulators containing specific antigens, and other targeted approaches that have been successfully demonstrated to have therapeutic effects on autoimmune diseases.
自身免疫性疾病的患病率正在稳步上升,但目前尚无永久性治愈方法。通过反复暴露抗原进行免疫调节,即所谓的抗原特异性免疫耐受或抗原特异性免疫治疗(ASI),是治疗或预防自身免疫性疾病的一种很有前途的方法。目前正在开发不同的优化方案(免疫途径、输送系统和方法),以针对自身蛋白实施 ASI。包括适当的佐剂、改变的肽配体以及使用多种肽都是可用于特异性靶向自身免疫的方法。本文综述了各种 ASI 应用方法,包括不同的抗原特异性致敏途径、输送系统、含有特定抗原的免疫调节剂以及其他已成功证明对自身免疫性疾病具有治疗效果的靶向方法。